255 related articles for article (PubMed ID: 27312202)
1. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
[TBL] [Abstract][Full Text] [Related]
2. Effect of prostaglandin I2 analogs on cytokine expression in human myeloid dendritic cells via epigenetic regulation.
Kuo CH; Lin CH; Yang SN; Huang MY; Chen HL; Kuo PL; Hsu YL; Huang SK; Jong YJ; Wei WJ; Chen YP; Hung CH
Mol Med; 2012 May; 18(1):433-44. PubMed ID: 22231731
[TBL] [Abstract][Full Text] [Related]
3. Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages.
Lin YC; Huang MY; Lee MS; Hsieh CC; Kuo HF; Kuo CH; Hung CH
J Microbiol Immunol Infect; 2018 Feb; 51(1):18-26. PubMed ID: 27325144
[TBL] [Abstract][Full Text] [Related]
4. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
5. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
[TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
Said MM; Bosland MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
[TBL] [Abstract][Full Text] [Related]
7. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
8. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
9. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood.
De Wit D; Tonon S; Olislagers V; Goriely S; Boutriaux M; Goldman M; Willems F
J Autoimmun; 2003 Nov; 21(3):277-81. PubMed ID: 14599853
[TBL] [Abstract][Full Text] [Related]
10. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma.
Frieri M; Therattil J; Wang SF; Huang CY; Wang YC
Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma.
Han TH; Jin P; Ren J; Slezak S; Marincola FM; Stroncek DF
J Immunother; 2009 May; 32(4):399-407. PubMed ID: 19342965
[TBL] [Abstract][Full Text] [Related]
12. Modulation of cytokine expression in human myeloid dendritic cells by environmental endocrine-disrupting chemicals involves epigenetic regulation.
Hung CH; Yang SN; Kuo PL; Chu YT; Chang HW; Wei WJ; Huang SK; Jong YJ
Environ Health Perspect; 2010 Jan; 118(1):67-72. PubMed ID: 20056579
[TBL] [Abstract][Full Text] [Related]
13. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
14. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
15. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
Zhou C; Shi X; Huang H; Zhu Y; Wu Y
Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
[TBL] [Abstract][Full Text] [Related]
16. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
Maeba S; Ichiyama T; Ueno Y; Makata H; Matsubara T; Furukawa S
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):670-4. PubMed ID: 15984600
[TBL] [Abstract][Full Text] [Related]
17. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
Offer S; Shoseyov D; Bibi H; Eliraz A; Madar Z
Nitric Oxide; 2003 Aug; 9(1):10-7. PubMed ID: 14559427
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation.
Wang YS; Chi KH; Chu RM
Vet Immunol Immunopathol; 2007 Aug; 118(3-4):186-98. PubMed ID: 17617471
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
Ujino M; Sugimoto N; Koizumi Y; Ro S; Kojima Y; Asae KH; Yamashita N; Ohta K; Nagase H
Allergol Int; 2017 Sep; 66S():S21-S26. PubMed ID: 28647381
[TBL] [Abstract][Full Text] [Related]
20. Mature dendritic cell suppression by IL-1 receptor antagonist on retinal pigment epithelium cells.
Sugita S; Kawazoe Y; Imai A; Usui Y; Iwakura Y; Isoda K; Ito M; Mochizuki M
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3240-9. PubMed ID: 23532521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
